EZH2-IN-13

CAS No. 1403255-41-3

EZH2-IN-13( —— )

Catalog No. M35760 CAS No. 1403255-41-3

EZH2-IN-13, a potent EZH2 inhibitor, exhibits potential anticancer activity and may be utilized to study diseases associated with EZH2 activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 235 Get Quote
10MG 377 Get Quote
25MG 725 Get Quote
50MG 1086 Get Quote
100MG 1683 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    EZH2-IN-13
  • Note
    Research use only, not for human use.
  • Brief Description
    EZH2-IN-13, a potent EZH2 inhibitor, exhibits potential anticancer activity and may be utilized to study diseases associated with EZH2 activity.
  • Description
    EZH2-IN-13 is a potent EZH2 inhibitor, for details please refer to compound 73 in patent WO2017139404. EZH2-IN-13 can be used to study cancers or precancerous lesions associated with EZH2 activity.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Histone Methyltransferase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1403255-41-3
  • Formula Weight
    571.75
  • Molecular Formula
    C34H45N5O3
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 125 mg/mL (218.63 mM; Ultrasonic )
  • SMILES
    CCN(C1CCOCC1)c1cc(cc(C(=O)NCc2c(C)cc(C)[nH]c2=O)c1C)-c1ccc(CN2CCNCC2)cc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Jesse Smith, et al. Methods of treating cancer. WO2017139404.
molnova catalog
related products
  • CEF27,Epstein-Barr V...

    HLA-A*0301-restricted epitope from Epstein-Barr Virus , EBV BRLF-1 (148-156).

  • Lanreotide acetate

    Lanreotide acetate (BIM 23014 acetate) has been used as an inhibitor to test the variability of h2s regulation in wild-type mice with growth hormone/thyroid hormone signal transduction.

  • Fenchlonine

    4-Chloro-DL-phenylalanine is a pharmaceutical intermediate.